Scientists studying relationships between different
types of cells have encountered some new and potentially important information
about how -- and when -- cancerous tumors grow most aggressively.
According to
a new study, cancerous tumors may grow faster at
night, during the hours typically taken up by sleep.
Their discovery may point
the way toward new, circadian-aligned strategies for treating cancer.
Researchers at Israel's Weizmann Institute of
Science have found evidence that suggests some cancers may grow more quickly
during nighttime, resting hours than during the waking day.
The finding came as a surprise to researchers, who
originally set out to examine the relationships between cell receptors,
molecules that are involved in cell-to-cell communications.
In particular,
researchers were investigating the relationship between two types of cell
receptors. The first receptor, EGFR (epidermal growth factor receptor), assists
in cell growth and division. EGFR is involved in normal cell growth, and also
in the growth of cancer cells.
High levels of EGFR are found in
many cancer cells, and one type of current cancer treatment works to fight
cancer by inhibiting EGFR levels.
The second receptor involves a type of steroid
hormone known as glutocorticoids (GC).
Glutocorticoids perform a number of essential functions, one of which
is a role in supporting daytime energy and alertness.
When the body is under
stress, levels of glutocorticoids rise sharply, heightening and sharpening a sense of
alertness. Cortisol, often referred to as the "stress hormone," is
one important glutocorticoid.
Glutocorticoid hormone levels rise and fall in
alignment with a 24-hour, circadian cycle. During active daytime hours, GC
levels are at their highest, when we need to be alert and energized. GC levels
plummet to their lowest levels at night during sleep, before rising again as
morning arrives.
Scientists investigated how the circadian changes in
GC hormone levels might affect the activity of EFGR, the receptor involved in
cell growth. Using mice, they discovered that EGFR is significantly more active
at night (when GC levels are low), and less active during the day (when GC
levels are high).
No comments:
Post a Comment